Publications

  1. Vizcaino MA, Giannini C, King RL, Johnson DR, Yang T, Raghunathan A. Primary Leptomeningeal Lymphoma: Clinicopathologic Features of 2 Rare Phenotypes. J Neuropathol Exp Neurol. 2022 Sep 14 Epub 2022 Sept 14
    View PubMed
  2. Johnson DR, Giannini C, Vaubel RA, Morris JM, Eckel LJ, Kaufmann TJ, Guerin JB. A Radiologist's Guide to the 2021 WHO Central Nervous System Tumor Classification: Part I-Key Concepts and the Spectrum of Diffuse Gliomas. Radiology. 2022 Sep; 304 (3):494-508 Epub 2022 July 26
    View PubMed
  3. Burkett BJ, Babcock JC, Lowe VJ, Graff-Radford J, Subramaniam RM, Johnson DR. PET Imaging of Dementia: Update 2022. Clin Nucl Med. 2022 Sep 1; 47 (9):763-773 Epub 2022 May 12
    View PubMed
  4. Badawy M, Johnson G, Jain M, Kendi AT, Johnson DR, Porter A, Yang M, Sonbol MB. Intracranial neuroendocrine tumour simulating meningioma for several years: an overview of diagnosis and treatment. BJR Case Rep. 2022 Sep; 8 (3):20210222 Epub 2022 Jan 27
    View PubMed
  5. Camerucci E, Graff-Radford J, Jones DT, Elder BD, Gunter JL, Cutsforth-Gregory JK, Botha H, Murphy MC, Johnson DR, Davidge-Pitts C, Jack CR Jr, Huston J 3rd, Cogswell PM. Change in Morphological Features of Enlarged Subarachnoid Spaces Following Treatment in Idiopathic Normal Pressure Hydrocephalus. J Magn Reson Imaging. 2022 Jul 27 Epub 2022 July 27
    View PubMed
  6. Babcock JC, Johnson DR, Benson JC, Kim DK, Luetmer PH, Shlapak DP, Cross CP, Johnson MP, Cutsforth-Gregory JK, Carr CM. Diffuse Calvarial Hyperostosis and Spontaneous Intracranial Hypotension: A Case-Control Study. AJNR Am J Neuroradiol. 2022 Jul; 43 (7):978-983 Epub 2022 June 30
    View PubMed
  7. Johnson DR, Glenn CA, Javan R, Olson JJ. Congress of Neurological Surgeons systematic review and evidence-based guidelines update on the role of imaging in the management of progressive glioblastoma in adults. J Neurooncol. 2022 Jun; 158 (2):139-165 Epub 2021 Oct 25
    View PubMed
  8. Carr CM, Benson JC, DeLone DR, Diehn FE, Kim DK, Ma D, Nagelschneider AA, Madhavan AA, Johnson DR. Manifestations of radiation toxicity in the head, neck, and spine: An image-based review. Neuroradiol J. 2022 May 1; 19714009221096824 Epub 2022 May 01
    View PubMed
  9. Neth BJ, Carabenciov ID, Ruff MW, Johnson DR. Temporal Trends in Glioblastoma Survival: Progress then Plateau. Neurologist. 2022 May 1; 27 (3):119-124 Epub 2022 May 01
    View PubMed
  10. Eschbacher KL, Johnson DR, Orozco-Do SL, Jawaid T, Schuetz AN, Nguyen AT. A 76-year-old male with multiple enhancing brain lesions. Brain Pathol. 2022 May; 32 (3):e13063 Epub 2022 Mar 10
    View PubMed
  11. Germano IM, Johnson DR, Patrick HH, Goodman AL, Ziu M, Ormond DR, Olson JJ. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Management of Progressive Glioblastoma in Adults: Update of the 2014 Guidelines. Neurosurgery. 2022 May 1; 90 (5):649-652
    View PubMed
  12. Broski SM, Johnson DR, Packard AT, Hunt CH. (18)F-fluorodeoxyglucose PET/Computed Tomography: Head and Neck Salivary Gland Tumors. PET Clin. 2022 Apr; 17 (2):249-263 Epub 2022 Feb 26
    View PubMed
  13. Chatzopoulos K, Eschbacher KL, Gurram PR, Huang J, Rinaldo L, Milone AA, Johnson DR, Shah AS, Wengenack NL, Schuetz AN, Parney IF, Trejo-Lopez JA. An 82-year-old man with a right frontal lobe rim-enhancing lesion. Brain Pathol. 2022 Mar; 32 (2):e13021 Epub 2021 Oct 04
    View PubMed
  14. Benson JC, Eschbacher KL, Raghunathan A, Johnson D, Kim DK, Van Gompel J. Cavernous Sinus Vascular Venous Malformation. AJNR Am J Neuroradiol. 2022 Jan; 43 (1):19-23 Epub 2021 Nov 11
    View PubMed
  15. Schuelke MR, Gundelach JH, Coffey M, West E, Scott K, Johnson DR, Samson A, Melcher A, Vile RG, Bram RJ. Phase I trial of sargramostim/pelareorep therapy in pediatric patients with recurrent or refractory high-grade brain tumors. Neurooncol Adv. 2022 Jan-Dec; 4 (1):vdac085 Epub 2022 June 17
    View PubMed
  16. Schroeder DG, Jang S, Johnson DR, Takahashi H, Navin PJ, Broski SM, Thorpe MP, Johnson GB, Young JR. Frequency and Characteristics of Nodal and Deltoid FDG and (11)C-Choline Uptake on PET Performed After COVID-19 Vaccination. AJR Am J Roentgenol. 2021 Nov; 217 (5):1206-1216 Epub 2021 May 19
    View PubMed
  17. Johnson BJ, Van Abel KM, Ma DJ, Johnson DR. (18)F-FDG-Avid Axillary Lymph Nodes After COVID-19 Vaccination. J Nucl Med 2021 Oct; 62 (10):1483-1484 Epub 2021 Mar 19
    View PubMed
  18. Parent EE, Johnson DR, Gleason T, Villanueva-Meyer JE. Neuro-Oncology Practice Clinical Debate: FDG PET to differentiate glioblastoma recurrence from treatment-related changes. Neurooncol Pract. 2021 Oct; 8 (5):518-525 Epub 2021 May 04
    View PubMed
  19. Ida CM, Johnson DR, Nair AA, Davila J, Kollmeyer TM, Minn K, Fadra NM, Balcom JR, Fung KA, Kim DK, Kaufmann TJ, Kipp BR, Halling KC, Jenkins RB, Giannini C. Polymorphous Low-Grade Neuroepithelial Tumor of the Young (PLNTY): Molecular Profiling Confirms Frequent MAPK Pathway Activation. J Neuropathol Exp Neurol. 2021 Sep 27; 80 (9):821-829
    View PubMed
  20. Eschbacher KL, Ida CM, Johnson DR, Alvi MA, Jenkins SM, Ruff MW, Kerezoudis P, Neth BJ, Pasion RM, Daniels DJ, Kizilbash SH, Raghunathan A. Diffuse Gliomas of the Brainstem and Cerebellum in Adults Show Molecular Heterogeneity. Am J Surg Pathol. 2021 Aug 1; 45 (8):1082-1090
    View PubMed
  21. Johnson DR, Waid MD, Rula EY, Hughes DR, Rosenkrantz AB, Duszak R. Comparison of Radiologists and Other Specialists in the Performance of Lumbar Puncture Procedures Over Time. AJNR Am J Neuroradiol. 2021 Jun; 42 (6):1174-1181 Epub 2021 Mar 04
    View PubMed
  22. Zahid A, Mark IT, Gilbertson JR, Johnson DR. Cerebral malaria with extensive subcortical microhemorrhages. Oxf Med Case Reports. 2021 May; 2021 (5):omab028 Epub 2021 May 24
    View PubMed
  23. Carr CM, Benson JC, DeLone DR, Diehn FE, Kim DK, Merrell KW, Nagelschneider AA, Madhavan AA, Johnson DR. Intracranial long-term complications of radiation therapy: an image-based review. Neuroradiology. 2021 Apr; 63 (4):471-482 Epub 2021 Jan 04
    View PubMed
  24. Johnson DR, Carr CM, Luetmer PH, Diehn FE, Lehman VT, Cutsforth-Gregory JK, Verdoorn JT, Krecke KN. Diffuse Calvarial Hyperostosis in Patients with Spontaneous Intracranial Hypotension. World Neurosurg. 2021 Feb; 146:e848-e853 Epub 2020 Nov 18
    View PubMed
  25. Zahid A, Johnson DR, Kizilbash SH. Efficacy of (177)Lu-Dotatate Therapy in the Treatment of Recurrent Meningioma. Mayo Clin Proc Innov Qual Outcomes. 2021 Feb; 5 (1):236-240 Epub 2021 Jan 14
    View PubMed
  26. Fogh SE, Boreta L, Nakamura JL, Johnson DR, Chi AS, Kurz SC. Neuro-Oncology Practice Clinical Debate: Early treatment or observation for patients with newly diagnosed oligodendroglioma and small-volume residual disease. Neurooncol Pract. 2021 Feb; 8 (1):11-17 Epub 2020 June 27
    View PubMed
  27. Muthusamy K, Hanna C, Johnson DR, Cramer CH, Tebben PJ, Libi SE, Poling GL, Lanpher BC, Morava E, Schimmenti LA. Growth hormone deficiency in a child with branchio-oto-renal spectrum disorder: Clinical evidence of EYA1 in pituitary development and a recommendation for pituitary function surveillance. Am J Med Genet A. 2021 Jan; 185 (1):261-266 Epub 2020 Oct 24
    View PubMed
  28. Stocksdale B, Nagpal S, Hixson JD, Johnson DR, Rai P, Shivaprasad A, Tremont-Lukats IW. Neuro-Oncology Practice Clinical Debate: long-term antiepileptic drug prophylaxis in patients with glioma. Neurooncol Pract. 2020 Dec; 7 (6):583-588 Epub 2020 May 20
    View PubMed
  29. Johnson GB, Harms HJ, Johnson DR, Jacobson MS. PET Imaging of Tumor Perfusion: A Potential Cancer Biomarker? Semin Nucl Med. 2020 Nov; 50 (6):549-561 Epub 2020 Aug 07
    View PubMed
  30. Neth BJ, Ruff MW, Uhm JH, Johnson DR, Divekar RD, Maddox DE. Temozolomide desensitization followed by metronomic dosing in patients with hypersensitivity. Cancer Chemother Pharmacol. 2020 Sep; 86 (3):375-382 Epub 2020 Aug 10
    View PubMed
  31. Jain R, Johnson DR, Patel SH, Castillo M, Smits M, van den Bent MJ, Chi AS, Cahill DP. "Real world" use of a highly reliable imaging sign: "T2-FLAIR mismatch" for identification of IDH mutant astrocytomas. Neuro Oncol. 2020 Jul 7; 22 (7):936-943
    View PubMed
  32. Palmer JD, Greenspoon J, Brown PD, Johnson DR, Roberge D. Neuro-Oncology Practice Clinical Debate: stereotactic radiosurgery or fractionated stereotactic radiotherapy following surgical resection for brain metastasis. Neurooncol Pract. 2020 Jun; 7 (3):263-267 Epub 2019 Oct 01
    View PubMed
  33. Mark IT, Carr CM, Ruff MW, Flanagan EP, Johnson DR. Enlarging Perivascular Spaces Following Radiation Therapy in the Brain: A Report of 2 Cases and Literature Review. World Neurosurg. 2020 Jun; 138:436-439 Epub 2020 Apr 03
    View PubMed
  34. Larson AS, Johnson DR, Lehman VT, Rinaldo L, Klaas J, Lanzino G, Savastano LE. Contemporary Management of Moyamoya Disease: Part II—Imaging Features and Grading Systems Contemporary Neurosurgery. 2020; 42(7):1-8. Epub 2020 Apr 30.
  35. Cogswell PM, Graff-Radford J, Wurtz LI, Graff-Radford NR, Johnson DR, Hunt CH, Gunter JL, Cutsforth-Gregory JK, Jones DT, Elder BD, Huston Iii J, Jack CR Jr. CSF dynamics disorders: Association of brain MRI and nuclear medicine cisternogram findings. Neuroimage Clin. 2020; 28:102481 Epub 2020 Oct 28
    View PubMed
  36. Johnson DR, Giannini C, Jenkins RB, Kim DK, Kaufmann TJ. Plenty of calcification: imaging characterization of polymorphous low-grade neuroepithelial tumor of the young. Neuroradiology. 2019 Nov; 61 (11):1327-1332 Epub 2019 Aug 09
    View PubMed
  37. Clark MS, Packard AT, Johnson DR, Johnson GB. Pitfalls of a Mixed Metabolic Response at PET/CT. Radiographics. 2019 Sep-Oct; 39 (5):1461-1475 Epub 2019 Aug 09
    View PubMed
  38. Black DF, Little JT, Johnson DR. Neuroanatomical Considerations in Preoperative Functional Brain Mapping. Top Magn Reson Imaging. 2019 Aug; 28 (4):213-224
    View PubMed
  39. Ehman , EC, Thompson , SM, Welch , BT, Johnson , DR, McGregor , HCJ. PET Imaging of Helatocellular Carcinoma Cur Radiol Rep. 2019.
  40. Johnson DR, Guerin JB, Ruff MW, Fang S, Hunt CH, Morris JM, Morris PP, Pearse Morris P, Kaufmann TJ. Glioma response assessment: Classic pitfalls, novel confounders, and emerging imaging tools. Br J Radiol. 2019 Feb; 92 (1094):20180730 Epub 2018 Nov 14
    View PubMed
  41. Johnson DR, Kaufmann TJ, Patel SH, Chi AS, Snuderl M, Jain R. There is an exception to every rule-T2-FLAIR mismatch sign in gliomas. Neuroradiology. 2019 Feb; 61 (2):225-227 Epub 2018 Dec 18
    View PubMed
  42. Ruff MW, Buckner JC, Johnson DR, van den Bent MJ, Geurts M. Neuro-Oncology Clinical Debate: PCV or temozolomide in combination with radiation for newly diagnosed high-grade oligodendroglioma. Neurooncol Pract. 2019 Jan; 6 (1):17-21 Epub 2018 Nov 03
    View PubMed
  43. Cerhan JH, Caine C, Anderson SK, Johnson DR, Lachance DH, Yan E, Brown PD. Preliminary exploration of a computerized cognitive battery and comparison with traditional testing in patients with high-grade glioma. Neurooncol Pract. 2019 Jan; 6 (1):71-77 Epub 2018 May 21
    View PubMed
  44. Cachia D, Johnson DR, Kaufmann TJ, Lowe S, Andersen S, Olar A, Cooper SL, Frankel BM, Gilbert MR. Case-based review: ependymomas in adults. Neurooncol Pract. 2018 Aug; 5 (3):142-153 Epub 2018 July 24
    View PubMed
  45. Ruff MW, Carabenciov ID, Johnson DR, Pollock BE, Parisi JE, Klaas JP. A cavernous sinus lesion clinically responsive to steroids. J Clin Neurosci. 2018 Jul; 53:239-240 Epub 2018 Apr 21
    View PubMed
  46. Johnson DR, Omuro AMP, Ravelo A, Sommer N, Guerin A, Ionescu-Ittu R, Shi S, Macalalad A, Uhm JH. Overall survival in patients with glioblastoma before and after bevacizumab approval. Curr Med Res Opin. 2018 May; 34 (5):813-820 Epub 2017 Nov 10
    View PubMed
  47. Johnson DR, Hunt CH, Nathan MA, Parisi JE, Boeve BF, Murray ME, Knopman DS, Jack CR Jr, Petersen RC, Lowe VJ, Johnson GB. Pittsburgh compound B (PiB) PET imaging of meningioma and other intracranial tumors. J Neurooncol. 2018 Jan; 136 (2):373-378 Epub 2017 Nov 08
    View PubMed
  48. Johnson DR, Campeau NG. Dual-Energy CT Differentiates Contrast Staining From Hemorrhagic Conversion of Ischemic Stroke. Neurohospitalist. 2018 Jan; 8 (1):42-43 Epub 2017 Apr 16
    View PubMed
  49. Bruinsma TJ, Johnson DR, Fang P, Senjem M, Josephs KA, Whitwell JL, Boeve BF, Pandey MK, Kantarci K, Jones DT, Vemuri P, Murray M, Graff-Radford J, Schwarz CG, Knopman DS, Petersen RC, Jack CR Jr, Lowe VJ. Uptake of AV-1451 in meningiomas. Ann Nucl Med. 2017 Dec; 31 (10):736-743 Epub 2017 Sept 08
    View PubMed
  50. Johnson DR, Guerin JB, Giannini C, Morris JM, Eckel LJ, Kaufmann TJ. 2016 Updates to the WHO Brain Tumor Classification System: What the Radiologist Needs to Know. Radiographics. 2017 Nov-Dec; 37 (7):2164-2180 Epub 2017 Oct 13
    View PubMed
  51. Graffeo CS, Leeper HE, Perry A, Uhm JH, Lachance DJ, Brown PD, Ma DJ, Van Gompel JJ, Giannini C, Johnson DR, Raghunathan A. Revisiting Adjuvant Radiotherapy After Gross Total Resection of World Health Organization Grade II Meningioma. World Neurosurg. 2017 Jul; 103:655-663 Epub 2017 Apr 24
    View PubMed
  52. Kalina P, Guerin JB, Johnson DR, Koch BL, Merrow AC, O'Brien WT. Pediatric Parotid Region Lesions: An imaging Review Neurographics. 2017; 33(1852).
  53. Johnson DR, Diehn FE, Giannini C, Jenkins RB, Jenkins SM, Parney IF, Kaufmann TJ. Genetically Defined Oligodendroglioma Is Characterized by Indistinct Tumor Borders at MRI. AJNR Am J Neuroradiol. 2017 Apr; 38 (4):678-684 Epub 2017 Jan 26
    View PubMed
  54. Maloney PR, Yamaki VN, Kumar R, Johnson D, Hunt C, Jentoft ME, Clarke M. Osteosclerosis Secondary to Metastatic Oligodendroglioma. Rare Tumors. 2017 Mar 24; 9 (1):6837 Epub 2017 Mar 31
    View PubMed
  55. Korfel A, Schlegel U, Johnson DR, Kaufmann TJ, Giannini C, Hirose T. Case-based review: primary central nervous system lymphoma. Neurooncol Pract. 2017 Mar; 4 (1):46-59 Epub 2017 Feb 09
    View PubMed
  56. Fogh SE, Johnson DR, Barker FG 2nd, Brastianos PK, Clarke JL, Kaufmann TJ, Oberndorfer S, Preusser M, Raghunathan A, Santagata S, Theodosopoulos PV. Case-Based Review: meningioma. Neurooncol Pract. 2016 Jun; 3 (2):120-134 Epub 2016 Jan 13
    View PubMed
  57. Johnson DR, Fogh SE, Giannini C, Kaufmann TJ, Raghunathan A, Theodosopoulos PV, Clarke JL. Case-Based Review: newly diagnosed glioblastoma. Neurooncol Pract. 2015 Sep; 2 (3):106-121 Epub 2015 July 21
    View PubMed
  58. Porter AB, Lachance DH, Johnson DR. Socioeconomic status and glioblastoma risk: a population-based analysis. Cancer Causes Control. 2015 Feb; 26 (2):179-185 Epub 2014 Nov 25
    View PubMed
  59. Johnson DR, Galanis E. Medical management of high-grade astrocytoma: current and emerging therapies. Semin Oncol. 2014 Aug; 41 (4):511-522 Epub 2014 June 30
    View PubMed
  60. Johnson DR, Leeper HE, Uhm JH. Glioblastoma survival in the United States improved after Food and Drug Administration approval of bevacizumab: a population-based analysis. Cancer. 2013 Oct 1; 119 (19):3489-95 Epub 2013 July 18
    View PubMed
  61. Johnson DR, Wefel JS. Relationship between cognitive function and prognosis in glioblastoma. CNS Oncol. 2013 Mar; 2 (2):195-201
    View PubMed
  62. Johnson DR, Galanis E. Incorporation of prognostic and predictive factors into glioma clinical trials. Curr Oncol Rep. 2013 Feb; 15 (1):56-63
    View PubMed
  63. Johnson DR, O'Neill BP, Decker PA, Kosel ML, Lanzino G, Hammack JE. Mortality and discharge to home after closed brain biopsy: analysis of 3523 cases from the State of California, 2003-2009. World Neurosurg. 2013 Jan; 79: (1)110-5.
    View PubMed
  64. Johnson DR, Ma DJ, Buckner JC, Hammack JE. Conditional probability of long-term survival in glioblastoma: a population-based analysis. Cancer. 2012 Nov 15; 118 (22):5608-13 Epub 2012 May 08
    View PubMed
  65. Johnson DR, Kaufmann TJ. Rapid symptomatic and radiographic evolution after presumed spontaneous infarction of a meningioma. Neurologist. 2012 Nov; 18(6):409-12.
    View PubMed
  66. Kamel H, Johnson DR, Hegde M, Go AS, Sidney S, Sorel M, Hills NK, Johnston SC. Detection of atrial fibrillation after stroke and the risk of recurrent stroke. J Stroke Cerebrovasc Dis. 2012 Nov; 21(8):726-31. Epub 2011 May 05.
    View PubMed
  67. Johnson DR, Sawyer AM, Meyers CA, O'Neill BP, Wefel JS. Early measures of cognitive function predict survival in patients with newly diagnosed glioblastoma. Neuro Oncol. 2012 Jun; 14 (6):808-16 Epub 2012 Apr 16
    View PubMed
  68. Johnson DR, Brown PD, Galanis E, Hammack JE. Pilocytic astrocytoma survival in adults: analysis of the Surveillance, Epidemiology, and End Results Program of the National Cancer Institute. J Neurooncol. 2012 May; 108 (1):187-93 Epub 2012 Feb 25
    View PubMed
  69. Johnson DR, O'Neill BP. Glioblastoma survival in the United States before and during the temozolomide era. J Neurooncol. 2012 Apr; 107 (2):359-64 Epub 2011 Nov 02
    View PubMed
  70. Lachance DH, Yang P, Johnson DR, Decker PA, Kollmeyer TM, McCoy LS, Rice T, Xiao Y, Ali-Osman F, Wang F, Stoddard SM, Sprau DJ, Kosel ML, Wiencke JK, Wiemels JL, Patoka JS, Davis F, McCarthy B, Rynearson AL, Worra JB, Fridley BL, O'Neill BP, Buckner JC, Il'yasova D, Jenkins RB, Wrensch MR. Associations of high-grade glioma with glioma risk alleles and histories of allergy and smoking. Am J Epidemiol. 2011 Sep 1; 174 (5):574-81 Epub 2011 July 08
    View PubMed
  71. Johnson DR, Olson JE, Vierkant RA, Hammack JE, Wang AH, Folsom AR, Virnig BA, Cerhan JR. Risk factors for meningioma in postmenopausal women: results from the Iowa Women's Health Study. Neuro Oncol. 2011 Sep; 13 (9):1011-9 Epub 2011 July 12
    View PubMed
  72. Johnson DR, Kimmel DW, Burch PA, Cascino TL, Giannini C, Wu W, Buckner JC. Phase II study of subcutaneous octreotide in adults with recurrent or progressive meningioma and meningeal hemangiopericytoma. Neuro Oncol. 2011 May; 13 (5):530-5
    View PubMed
  73. Jenkins RB, Wrensch MR, Johnson D, Fridley BL, Decker PA, Xiao Y, Kollmeyer TM, Rynearson AL, Fink S, Rice T, McCoy LS, Halder C, Kosel ML, Giannini C, Tihan T, O'Neill BP, Lachance DH, Yang P, Wiemels J, Wiencke JK. Distinct germ line polymorphisms underlie glioma morphologic heterogeneity. Cancer Genet. 2011 Jan; 204 (1):13-8
    View PubMed
  74. Kamel H, Hegde M, Johnson DR, Gage BF, Johnston SC. Cost-effectiveness of outpatient cardiac monitoring to detect atrial fibrillation after ischemic stroke. Stroke. 2010 Jul; 41(7):1514-20. Epub 2010 May 27.
    View PubMed